Concepedia

Matthew A. Seager

MA

Statistics

Publications

30

Citations

1.5K

H-Index

23

Active since

1997

Affiliations

United States Military Academy(Current)

Miami University

Eli Lilly (United States)

Bristol-Myers Squibb (United States)

Merck & Co., Inc., Rahway, NJ, USA (United States)

Matthew A. Seager is an author at United States Military Academy specializing in pharmacology, neuroscience, and neuropharmacology.

Publications per year

1997–2018

30

Publications

30

Selective activation of the M <sub>1</sub> muscarinic acetylcholine receptor achieved by allosteric potentiation

Lei Ma, Matthew A. Seager, Marion Wittmann et al. · Proceedings of the National Academy of Sciences · 2009 · 284 citations · Full text

, , +17

Oscillatory brain states and learning: Impact of hippocampal theta-contingent training

Matthew A. Seager, Lynn D. Johnson, Elizabeth S. Chabot et al. · Proceedings of the National Academy of Sciences · 2002 · 203 citations

, , +17

Inhibition of Calcineurin-mediated Endocytosis and α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (AMPA) Receptors Prevents Amyloid β Oligomer-induced Synaptic Disruption

Weiqin Zhao, Francesca Santini, Robert Breese et al. · Journal of Biological Chemistry · 2009 · 183 citations · Full text

, , +17

Quinolizidinone Carboxylic Acids as CNS Penetrant, Selective M<sub>1</sub> Allosteric Muscarinic Receptor Modulators

Scott D. Kuduk, Ronald K. Chang, Christina N. Di Marco et al. · ACS Medicinal Chemistry Letters · 2010 · 68 citations · Full text

, , +16

Discovery of a Selective Allosteric M<sub>1</sub>Receptor Modulator with Suitable Development Properties Based on a Quinolizidinone Carboxylic Acid Scaffold

Scott D. Kuduk, Ronald K. Chang, Christina N. Di Marco et al. · Journal of Medicinal Chemistry · 2011 · 62 citations · Full text

, , +17

1–5 of 30